ALLMedicine™ Alveolar Soft Part Sarcoma Center
Research & Reviews 97 results
https://doi.org/10.1016/j.ctrv.2021.102260
Cancer Treatment Reviews; Martínez-Trufero J, Cruz Jurado J et. al.
Aug 3rd, 2021 - Among all Soft Tissue sarcomas there are some subtypes with low incidence and/or peculiar clinical behaviour, that need to be consider separately. Most of them are orphan diseases, whose biological characteristics imply a clearly different diagnos...
https://doi.org/10.1016/j.currproblcancer.2021.100775
Current Problems in Cancer; O'Sullivan Coyne G, Naqash AR et. al.
Jul 22nd, 2021 - Alveolar Soft Part Sarcoma is one of the less commonly diagnosed soft tissue sarcoma subtypes, an infrequent subtype within the already rare category of human malignancy of sarcoma. In this article we will summarize the histopathological features,...
https://doi.org/10.1177/10668969211027293
International Journal of Surgical Pathology; Caporalini C, Giordano F et. al.
Jun 19th, 2021 - Alveolar soft part sarcomas (ASPSs) are rare malignant tumors representing ∼1% of all soft tissue sarcomas. Most ASPS occurring in the central nervous system are metastases. In contrast, primary intracranial ASPSs are extremely rare and only 8 cas...
https://doi.org/10.1177/00034894211021261
The Annals of Otology, Rhinology, and Laryngology; Lucas JC, Karadaghy OA et. al.
May 29th, 2021 - Alveolar soft part sarcoma is a rare subset of soft tissue sarcomas, typically presenting in subjects 15 to 35 years of age. Usual presentation sites are the trunk, extremities, and the head and neck. Subjects younger than 5 years are rarely affec...
https://doi.org/10.1007/s00259-021-05388-y 10.1007/s00259-020-04769-z 10.2967/jnumed.119.227967
European Journal of Nuclear Medicine and Molecular Imaging; Zhou X, Wang S et. al.
May 14th, 2021 - Imaging superiority of 68Ga-FAPI-04 over [18F]-FDG PET/CT in alveolar soft part sarcoma (ASPS).|2021|Zhou X,Wang S,Zhu H,Yang Z,Li N,|
News 3 results
https://www.mdedge.com/sarcomajournal/article/177893/sarcoma-gist/tkis-and-immunotherapy-hold-promise-alveolar-soft-part
Roxanne Nelson
Oct 23rd, 2018 - Alveolar soft part sarcoma (ASPS) has often proven to be resistant to conventional doxorubicin-based chemotherapy, but tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) may provide new treatment strategies for this rare typ.
https://www.medscape.com/viewarticle/533958_3
Jul 5th, 2006 - Discussion The exact cause of ASPS is not entirely understood; however, studies indicate that genetic alterations may play a role. Certain inherited conditions are associated with an increased risk of developing soft-tissue sarcomas, including Li-...
https://www.medscape.com/viewarticle/533958
Jul 5th, 2006 - Introduction Alveolar soft part sarcoma (ASPS), also called alveolar soft-tissue sarcoma (ASTS), is a rare malignant soft-tissue neoplasm, which was first described by Christopherson and colleagues[1] in 1952. Its prevalence is less than 1% of all...
